GB virus C/hepatitis G virus infection in southern China

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 168-171

  Wu, Rong Rong ^b   Mizokami, Masashi ^a   Cao, Kun ^b   Nakano, Tatsunori ^b   Ge, Xian Min ^b   Wang, Su Seng ^b   Orito, Etsuro ^b   Ohba, Ken Ichi ^b   Mukaide, Motokazu ^b   Hikiji, Kazumasa ^b   Lau, Johnson Y N ^b   Iino, Shiro ^b  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINA; HEPATITIS; HEPATITIS VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 16944364987     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.168     Document Type: Article

References (15)

1. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-9.
2. Linnen J, Wages J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271:505-8.
3. Muerhoff AS, Leary TP, Simons JN, et al. Genomic organization of GB viruses A and B: two new members of the flaviviridae associated with GB agent hepatitis. J Virol 1995; 69:5621-30.
4. Ohba KI, Mizokami M, Lau JYN, Onto E, Ikeo K, Gojobori T. Evolutionary relationship of hepatitis C, pesti-, flavi-, plant viruses, and newly discovered GB hepatitis agents. FEBS Lett 1996;378:232-4.
5. Zuckerman AJ. Alphabet of hepatitis viruses. Lancet 1996;347:558-9.
6. World Health Organization WPRIO. Report of scientific group on viral hepatitis and its related liver diseases. Geneva: WHO, 1982.
7. Gojobori T, Ishii K, Nei M. Estimation of average number of nucleotide substitutions when the rate of substitution varies. J Mol Evol 1982; 28: 414-23.
8. Saitou N, Nei M. The neighbor-joining method: a new method for reconstruction phylogenetic tree. Mol Biol Evol 1987; 4:406-25.
9. Ina Y. ODEN: a program package for molecular evolutionary analysis and database search of DNA and amino acid sequences. Comput Appl Biosci 1994; 10:11-2.
10. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346:1131-2.
11. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C [letter]. N Engl J Med 1996; 334:195-6.
12. Zuckerman AJ. The new GB hepatitis viruses. Lancet 1996; 345:1453-4.
13. Wu RR, Mizokami M, Lau JYN, et al. Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J Med Virol 1995; 45:174-8.
14. Tsukiyama-Kohara K, Iizuka N, Kohara M, et al. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992; 66:1478-81.
15. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19:1331-4.